Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maura Corsetti

Showing results (11-20 of 117) with videos related to

Pageof 12
Sort By:
Digestion|January 4, 2005
Are symptom-based diagnostic criteria for irritable bowel syndrome useful in clinical practice?Maura Corsetti, Jan Tack
Best Practice & Research. Clinical Gastroenterology|August 25, 2004
How to improve drug development for functional disordersJan Tack, Maura Corsetti
Expert Review of Gastroenterology & Hepatology|March 10, 2017
New therapeutic options for IBS: the role of the first in class mixed µ- opioid receptor agonist and δ-opioid receptor antagonist (mudelta) eluxadolineMaura Corsetti, Peter Whorwell
United European Gastroenterology Journal|June 12, 2014
Linaclotide: A new drug for the treatment of chronic constipation and irritable bowel syndrome with constipationMaura Corsetti, Jan Tack
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 15, 2023
Symptom Subgroups Taking Into Account Psychological Burden Predicts Irritable Bowel Syndrome Disease Impact and Burden: A Step Forward?Maura Corsetti, Sarah Ballou
Expert Review of Gastroenterology & Hepatology|September 16, 2014
Naloxegol for the treatment of opioid-induced constipationJan Tack, Maura Corsetti
Expert Opinion on Pharmacotherapy|March 26, 2014
New pharmacological treatment options for chronic constipationMaura Corsetti, Jan Tack
Alimentary Pharmacology & Therapeutics|November 15, 2024
Editorial: Rebuilding Rome-Revising Diagnostic Criteria for Irritable Bowel SyndromeMohsin F Butt, Maura Corsetti
The Practitioner|October 13, 2015
Managing irritable bowel syndrome in primary careMaura Corsetti, Peter J Whorwell
Neurogastroenterology and Motility|August 16, 2022
Hyoscine butylbromide mode of action on bowel motility: From pharmacology to clinical practiceMaura Corsetti, Sylvie Forestier, Marcel Jiménez
Pageof 12

Showing results (11-20 of 117) with videos related to

Sort By:
Pageof 12
Digestion|January 4, 2005
Are symptom-based diagnostic criteria for irritable bowel syndrome useful in clinical practice?Maura Corsetti, Jan Tack
Best Practice & Research. Clinical Gastroenterology|August 25, 2004
How to improve drug development for functional disordersJan Tack, Maura Corsetti
Expert Review of Gastroenterology & Hepatology|March 10, 2017
New therapeutic options for IBS: the role of the first in class mixed µ- opioid receptor agonist and δ-opioid receptor antagonist (mudelta) eluxadolineMaura Corsetti, Peter Whorwell
United European Gastroenterology Journal|June 12, 2014
Linaclotide: A new drug for the treatment of chronic constipation and irritable bowel syndrome with constipationMaura Corsetti, Jan Tack
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 15, 2023
Symptom Subgroups Taking Into Account Psychological Burden Predicts Irritable Bowel Syndrome Disease Impact and Burden: A Step Forward?Maura Corsetti, Sarah Ballou
Expert Review of Gastroenterology & Hepatology|September 16, 2014
Naloxegol for the treatment of opioid-induced constipationJan Tack, Maura Corsetti
Expert Opinion on Pharmacotherapy|March 26, 2014
New pharmacological treatment options for chronic constipationMaura Corsetti, Jan Tack
Alimentary Pharmacology & Therapeutics|November 15, 2024
Editorial: Rebuilding Rome-Revising Diagnostic Criteria for Irritable Bowel SyndromeMohsin F Butt, Maura Corsetti
The Practitioner|October 13, 2015
Managing irritable bowel syndrome in primary careMaura Corsetti, Peter J Whorwell
Neurogastroenterology and Motility|August 16, 2022
Hyoscine butylbromide mode of action on bowel motility: From pharmacology to clinical practiceMaura Corsetti, Sylvie Forestier, Marcel Jiménez
Pageof 12